Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association

Guideline Heart Rhythm
DOI: 10.1093/europace/euae178 Publication Date: 2024-06-28T13:11:21Z
AUTHORS (121)
ABSTRACT
Abstract Aims The aim is to describe the rationale, design, delivery, and baseline characteristics of Stroke prevention rhythm control Treatment: Evaluation an Educational programme European society cardiology in a cluster-Randomized trial patients with Atrial Fibrillation (STEEER-AF) trial. Methods results STEEER-AF pragmatic designed objectively robustly determine whether guidelines are adhered routine practice evaluate targeted educational for healthcare professionals. Seventy centres were randomized six countries (France, Germany, Italy, Poland, Spain, UK; 2022–23). recruited 1732 diagnosis atrial fibrillation (AF), mean age 68.9 years (SD 11.7), CHA2DS2-VASc score 3.2 1.8), 647 (37%) women. Eight hundred forty-three (49%) AF at enrolment 760 (44%) sinus rhythm. Oral anticoagulant therapy was prescribed 1543 (89%), majority receiving direct oral anticoagulants (1378; 89%). Previous cardioversion, antiarrhythmic drug therapy, or ablation recorded 836 (48.3%). Five fifty-one (31.8%) currently drug, 446 (25.8%) scheduled receive future cardioversion ablation. engaged 195 professionals across intervention group, consisting bespoke interactive online learning reinforcement activities, supported by national expert trainers. Conclusion successfully deployed investigate guideline adherence real-world if structured can improve patient-level care. Clinical Trial Registration Clinicaltrials.gov, NCT04396418.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (4)